SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ajanta Pharma

Ajanta Pharma

BSE: 532331|NSE: AJANTPHARM|ISIN: INE031B01049|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 30, 16:01
2004.20
5.65 (0.28%)
VOLUME 4,735
LIVE
NSE
Sep 30, 16:01
2007.10
2.15 (0.11%)
VOLUME 72,764
Download Annual Report PDF Format 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Ajanta Pharma

------------------- in Rs. Cr. -------------------
Jun '16 Mar '16 Dec '15 Sep '15 Jun '15
Net Sales/Income from operations 396.18 395.12 412.96 386.30 334.88
Other Operating Income 16.81 6.53 7.07 3.20 5.70
Total Income From Operations 412.99 401.65 420.03 389.50 340.58
EXPENDITURE
Consumption of Raw Materials 94.44 101.26 117.34 100.75 77.86
Purchase of Traded Goods 10.81 18.36 11.85 13.64 13.96
Increase/Decrease in Stocks -3.04 -18.05 -17.16 -8.11 2.30
Power & Fuel -- -- -- -- --
Employees Cost 64.78 63.53 58.47 58.83 54.55
Depreciation 12.43 11.55 11.12 10.31 9.70
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 103.01 107.31 100.31 96.84 82.10
P/L Before Other Inc. , Int., Excpt. Items & Tax 130.56 117.69 138.10 117.24 100.11
Other Income 8.48 41.61 4.20 23.04 13.53
P/L Before Int., Excpt. Items & Tax 139.04 159.30 142.30 140.28 113.64
Interest 0.88 0.93 1.31 0.93 1.03
P/L Before Exceptional Items & Tax 138.16 158.37 140.99 139.35 112.61
Exceptional Items -- -- -- -- --
P/L Before Tax 138.16 158.37 140.99 139.35 112.61
Tax 38.25 22.66 37.65 44.98 31.55
P/L After Tax from Ordinary Activities 99.91 135.71 103.34 94.37 81.06
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 99.91 135.71 103.34 94.37 81.06
Equity Share Capital 17.69 17.69 17.69 17.69 17.69
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 11.35 15.42 11.74 10.73 9.21
Diluted EPS 11.35 15.42 11.74 10.72 9.21
EPS After Extra Ordinary
Basic EPS 11.35 15.42 11.74 10.73 9.21
Diluted EPS 11.35 15.42 11.74 10.72 9.21
Public Share Holding
No Of Shares (Crores) -- -- -- 2.31 2.31
Share Holding (%) -- -- -- 26.22 26.22
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- 0.27 0.10
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- 4.08 1.54
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- 3.01 1.14
b) Non-encumbered
- Number of shares (Crores) -- -- -- 6.23 6.39
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- 95.92 98.46
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- 70.77 72.64
Notes Notes To The Accounts
Source : Dion Global Solutions Limited
Quick Links for ajantapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.